Related Experiment Video
Updated: May 26, 2026
07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling
Yongnan Fu1, Han Xiao, Youyi Zhang
1Institute of Vascular Medicine, Peking University Third Hospital and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 100191, PR China.
Frontiers in Bioscience (Elite Edition)
|December 29, 2011
Summary
Chronic stimulation of beta-adrenoceptors (ARs) contributes to adverse cardiac remodeling and heart failure. Understanding these pathways is crucial for developing new heart failure treatments.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Beta-adrenoceptors (ARs), part of the G protein-coupled receptor (GPCR) superfamily, are vital for rapid myocardial function regulation.
- Chronic stimulation of beta-ARs by catecholamines is linked to adverse cardiac remodeling, including hypertrophy, fibrosis, and apoptosis, ultimately leading to heart failure.
Purpose of the Study:
- To review signaling pathways involved in cardiac pathological remodeling.
- To highlight the role of chronic adrenergic stimulation in heart failure development.
- To identify potential therapeutic targets for heart failure.
Main Methods:
- Literature review of signaling pathways.
- Analysis of studies on chronic adrenergic stimulation and cardiac remodeling.
- Synthesis of information on beta-AR-mediated effects.
Main Results:
- Chronic beta-AR stimulation drives maladaptive cardiac remodeling.
- Sympathetic hyperactivity is a key factor in heart failure progression.
- Beta-blockers improve outcomes but do not fully resolve heart failure.
Conclusions:
- Understanding beta-AR signaling in cardiac remodeling is essential for novel heart failure therapies.
- Targeting specific pathways may offer new treatment strategies.
- Further research into these mechanisms is warranted.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:31Sympathetic Signaling
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...